Why Are Our Hematopoietic Stem Cells in the Bone Marrow?

Louisville Hematology Highlights

R. Gale

Pulmonary Embolism: Role of Catheter-Based Interventions

Baylor College of Medicine

P. Loyalka

Current Treatment Guidelines for ITP: Individualized Therapy and Eme…

Irina Murakhovskaya

Is There a Role for Splenectomy in ITP?

Platelet Disorder Support Association (PDSA)

C. Kessler

Thrombocytopenia: Understanding Mechanisms and Inherited Forms

Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course

S. Panch

Anemia and Thrombocytopenia Basics

UNC Lineberger Comprehensive Cancer Center

N. Vogler

Recent Advances in Classical Hematology

Indy Hematology Review

R. Brodsky

ASH 2024 Summary: Overview of Non-Surgical Management of Heavy Menst…

2024 ASH Annual Meeting Insights Hub

A. Wheeler

The Role of Complement in Disease: Focus on PNH, aHUS, CAPS, and CAD

Ilene Weitz

Key Insights on the FDA Approval of Marstacimab for Hemophilia

Akshat Jain

Natural History of ITP: Navigating the Journey

Platelet Disorder Support Association (PDSA)

D. Kuter

Are All New ITP Treatments Better Than Old Ones: Other Treatments to…

Platelet Disorder Support Association (PDSA)

H. Liebman

Management of Treatment-Naive ITP Patients

Weill Cornell Medicine Oncology & Hematology

J. Bussel

ITP: Diagnosis, Pathophysiology, and Management Guidelines

Songphol Tungjitviboonkun

Where Does Rituximab Fit in ITP

Platelet Disorder Support Association (PDSA)

D. Nugent

Pomalidomide for Epistaxis in Hereditary Hemorrhagic Telangiectasia:…

Massachusetts General Hospital Cancer Center

H. Al-Samkari

2024 Benign Hematology Updates

University of Colorado Division of Hematology

L. Chu

Sequencing Treatments in Hemophilia A: When to Switch and Why

Cedric R. Hermans

Causes of Secondary ITP and Long-Term Risk of Other Diseases in ITP …

Platelet Disorder Support Association (PDSA)

D. Kuter